ADVANCED
WOUND CARE

ELEVATING THE STANDARD OF CARE

From effectively managing a variety of wounds to efficiently navigating the reimbursement process, the journey to healing presents unique challenges for both you and your patients.

Designed for the management of chronic and acute wounds, our portfolio of advanced wound care solutions can support patients from early in the wound healing process through to wound closure—regardless of wound type.

  • PuraPly AM
    PuraPly XT
    PuraPly AM and PuraPly XT

    POWER OF PLUS

    The unique combination of a native ECM scaffold + broad-spectrum PHMB antimicrobial for next-level wound healing support.

    Discover how PuraPly AM and PuraPly XT support wound healing and aid in granulation tissue formation.

    LEARN MORE
  • Apligraf

    THE GOLD STANDARD PROVEN TO ACCELERATE HEALING

    Skin substitute bioengineered with living cells to transform VLUs and DFUs from chronic to acute.6-11

    Review the unmatched RCT proof, real-world results, and patient access for Apligraf®.

    REVIEW THE EVIDENCE
  • Affinity
    Novachor

    LIVING CELLS.
    FRESH SOLUTIONS.

    Never dehydrated or frozen, Affinity and Novachor are human placental allografts preserved in a fresh state—retaining native living cells, an intact extracellular matrix, and a variety of growth factors and cytokines. As a protective barrier and ECM scaffold, they may be used to support healing in a variety of partial- and-full-thickness acute and chronic wounds12-18

    Learn how various preservation methods can drastically impact product characteristics and cell viability.12,15,18-22

    SEE THE DIFFERENCE
  • CYGNUS Dual
    CYGNUS Dual. DUAL-LAYERED OMNI-DIRECTIONAL APPLICATION

    DUAL-LAYERED

    OMNI-DIRECTIONAL APPLICATION

    As a dual-layered, dehydrated human amniotic membrane with the epithelial layers facing outward, CYGNUS® Dual allows omni-directional application.

    Discover how CYGNUS Dual helps support an optimal environment for healing while streamlining product application and practice logistics.

    SEE THE DUAL LAYERS
  • NuShield

    CONVENIENCE WITHOUT COMPROMISE

    A complete dehydrated placental allograft that retains all layers of the amnion/chorion membrane.23-25 NuShield provides a protective barrier and ECM scaffold to support the body's inherent healing process.12,15,27

    See how NuShield® supported healing in a variety of wounds.26

    VIEW CASE STUDIES
  • VIA Matrix
    VIA Matrix. MULTI-LAYERED PLACENTAL ALLOGRAFT

    MULTI-LAYERED PLACENTAL ALLOGRAFT

    VIA Matrix™ is a multi-layer placental membrane allograft, which includes the amnion layer, the intermediate/spongy layer, and the chorion layer. The layers are never delaminated so structural integrity is maintained.

    Discover how VIA Matrix supports an optimal environment for healing while streamlining practice logistics.

    SEE THE MULTI-LAYERED DIFFERENCE

PATIENT & PROVIDER SUPPORT

Our Circle of Care program provides the highest level of support, helping both patients and healthcare professionals navigate every step of the healing journey.

GET SUPPORT

RESOURCES

Our teams of reimbursement and regulatory specialists help fulfill our commitment to providing the most advanced regenerative healing solutions available.

SEE RESOURCES

QUESTIONS?

Talk to a local Organogenesis specialist today to learn more about our innovative solutions.

CONTACT US

DFU=diabetic foot ulcer; ECM=extracellular matrix; PHMB=polyhexamethylene biguanide; VLU=venous leg ulcer

References:

  1. PuraPly Antimicrobial [package insert]. Canton, MA: Organogenesis Inc: 2020.
  2. PuraPly Antimicrobial XT [package insert]. Canton, MA: Organogenesis Inc; 2020.
  3. Brantley J, et al. Wounds Int. 2016;7(3):1-5.
  4. Davis SC, et al. Int Wound J. 2022:19(1):86-99.
  5. Bain MA, et al. J Comp Eff Res. 2020;9(10):691-703.
  6. Apligraf [package insert]. Canton, MA: Organogenesis Inc: 2017.
  7. Milstone LM, et al. Wounds. 2000:12(5 suppl A):12A-19A.
  8. Schmid P. Wounds. 2000:12(5 suppl A):4A-11A.
  9. Carlson M, et al. Tissue Eng Part A. 2011;17(3-4):487-493.
  10. Stone RC, et al. Sci Transl Med. 2017;9(371):eaaf8611. doi:10.1126/scitranslmed.aaf8611
  11. Stone RC, et al. Wound Repair Regen. 2019. doi:10.1111/wrr.12778
  12. McQuilling JP, et al. Int Wound J. 2017;14(6):993-1005.
  13. Data on file. DR-0006. Organogenesis Inc.
  14. Data on file. Nov_DR-0005. Organogenesis Inc.
  15. Data on file. Nov_DR-0007. Organogenesis Inc.
  16. Data on file. AF_DR-0014. Organogenesis Inc.
  17. Data on file. AF_DR-0013. Organogenesis Inc.
  18. Data on file. Nov_DR-0009. Organogenesis Inc.
  19. Brantley JN, et al. Adv Wound Care. 2015;4(9):545-559.
  20. Cooke M, et al. J Wound Care. 2014;23(10):465-474, 476.
  21. Johnson A, et al. Ann Plast Surg. 2017;79(2):203-213.
  22. Tan EK, et al. J Biomater Tissue Eng. 2014;4:379-388.
  23. Allograft Tissue Information and NuShield® Instructions for Use. Canton, MA: Organogenesis Inc; 2020.
  24. McQuilling JP, et al. Int Wound J. 2019;16(3):827-840.
  25. Data on file. Description of BioLoc Process. Organogenesis Inc.
  26. Caporusso J, et al. Wounds. 2019;31(4 Suppl):S19-S27.
  27. NS_DR-007. Organogenesis Inc.